INTRODUCTION
Accumulation of amyloid-b (Ab) in the extracellular space of the brain appears to be critical for developing synaptic and cognitive deficits in Alzheimer's disease (AD) (Palop and Mucke, 2010) . Ab is produced by sequential limited proteolysis of the amyloid precursor protein (APP), a type I single-transmembrane-span protein (Kang et al., 1987) , by two aspartyl proteases, b-and g-secretases. Normally, g-secretase cleavage results in variable 38-to 43-amino-acid Ab peptides, with Ab40 monomers as the predominant species. The biophysical and biochemical properties of Ab strongly depend on its concentration, length, and primary structure. Gradual elevation of Ab monomers in limbic and association cortices leads to its aggregation into oligomers, prefibrillar assemblies (protofibrils), and amyloid fibrils. All of these Ab forms may be in dynamic equilibrium, leading to a high variety of synaptic and circuit dysfunctions that underlie progressive cognitive impairments in AD (Mucke and Selkoe, 2012) . Transient upregulation of Ab production or application of pathological Ab levels depresses excitatory synaptic transmission (Hsia et al., 1999; Kamenetz et al., 2003) . Soluble Ab oligomers have been suggested to cause postsynaptic depression of glutamatergic transmission via loss of dendritic spines, blockade of long-term potentiation, and increase in long-term synaptic depression (Shankar et al., 2008; Walsh et al., 2002) .
While pathological Ab concentrations and assembly forms depress excitatory synaptic function through postsynaptic mechanisms, an increase in endogenous Ab levels induced by inhibition of extracellular Ab degradation causes presynaptic enhancement (Abramov et al., 2009) . Specifically, inhibition of the Ab-degrading enzyme neprilysin augmented glutamate release probability, reduced short-term facilitation of excitatory synaptic currents, and increased excitation-inhibition balance in hippocampal circuits (Abramov et al., 2009) . Because hippocampal and cortical hyperactivity is common in various transgenic AD mouse models (Busche et al., 2008 (Busche et al., , 2012 Palop et al., 2007; Verret et al., 2012) , in humans with mild cognitive impairments (Bakker et al., 2012) , and in AD patients (Vossel et al., 2013) , elucidating the synaptic mechanisms of hyperactivity is critical for understanding AD-associated cognitive impairments.
In the current study, we explored the mechanism initiating augmentation of synaptic vesicle release at excitatory hippocampal synapses by increasing the extracellular Ab concentration ([Ab] o ) in cultured hippocampal neurons and acute hippocampal slices. Utilizing a combination of fluorescence resonance energy transfer (FRET) spectroscopy, a singlemolecule imaging, two-photon excitation laser scanning microscopy combined with fluorescence lifetime imaging (2pFLIM), biochemistry, and imaging of synaptic vesicle recycling and of calcium, we found that the APP homodimer constitutes a presynaptic Ab40 receptor mediating the regulation of release probability at excitatory hippocampal synapses.
RESULTS

APP Is Essential for Ab-Mediated Presynaptic Enhancement
Concentrations of Ab in the synaptic cleft are determined by the balance of Ab production, release, and degradation. We have previously shown that inhibition of neprilysin, an Ab-degrading enzyme, increases release probability in excitatory hippocampal synapses (Abramov et al., 2009) . Inhibition of neprilysin was ineffective in APP À/À neurons, suggesting that APP and/or Ab mediate the presynaptic enhancement. Here, we wished to determine whether APP, in addition to being the source for Ab, is also necessary for Ab-induced signaling leading to the augmentation of basal transmitter release. We examined the effect of human Ab 1-40 (Ab40), the most abundant Ab isoform, on basal synaptic vesicle recycling in cultured hippocampal neurons using the activity-dependent dye FM1-43 as described earlier (Abramov et al., 2009) . To this end, we quantified the total amount of releasable fluorescence at each bouton (DF) and the density of FM + puncta per image (D) following stimulation (30 action potentials at a rate of 0.2 Hz; Figure S1A ) in the presence of 10 mM FM1-43. Figure 1A illustrates a typical high-magnification DF image before and after Ab40 application. The total presynaptic strength within a given region of the hippocampal network (S) can be estimated as the product of DF and D (S = DF 3 D). First, we measured the effect of size-exclusion chromatography-isolated Ab40 monomers ( Figure S2 ) on synaptic vesicle turnover in cultured hippocampal neurons from wildtype (WT) mice. Our results demonstrate that acute application of Ab40 monomers (100 pM, 15 min) induced a substantial increase in both DF and D across synaptic populations, resulting in a 2-fold increase in the total presynaptic strength S in WT neurons (Figures 1B and 1C) . The collective results of these experiments show a profound increase of S by Ab40 monomers in a concentration-dependent manner ( Figure 1I ). Application of rat Ab40 monomers produced a similar effect on presynaptic strength (data not shown). Because covalently crosslinked Ab40 dimers ([Ab40S26C] 2 ) have been shown to enhance Ca 2+ transients in CA1 hippocampal neurons in vivo (Busche et al., 2012) , we assessed their effects (O'Nuallain et al., 2010; Figure S2) on presynaptic function. Notably, fresh [Ab40S26C] 2 produced a presynaptic enhancement (100 pM; Figure 1D ) similar to the one induced by 100 pM Ab40 monomers. Next, we assessed the effect of Ab40 in hippocampal neurons produced from APP À/À (Zheng et al., 1995) mice. Surprisingly, the same concentrations of Ab40 monomers or Ab40S26C dimers that increased presynaptic activity in WT neurons were ineffective in neurons lacking APP ( Figures 1E-1I ). Expression of WT APP in APP À/À neurons rescued the presynaptic effect of Ab40 ( Figure S1B ), suggesting that both Ab40 and its precursor, APP, are essential for augmentation of synaptic vesicle recycling. Notably, the presynaptic Ab40 effect was not altered by several Ab binding candidates such as cellular prion protein (PrP C ) or a7 nicotinic acetylcholine receptor (a7nAChR), because Ab40 was still able to potentiate synaptic vesicle recycling in hippocampal neurons produced from PrP C knockout mice or following blockade of a7nAChR by a-bungarotoxin ( Figure S1B ). Taken together, these results suggest that APP is necessary for the presynaptic signaling mediated by Ab40 monomers and dimers.
Monitoring APP-APP Interactions at Individual Hippocampal Boutons Previous studies in heterologous expression systems suggest that APP molecules can form homodimers and that APP homodimerization may regulate Ab production (Eggert et al., 2009; Munter et al., 2007) . Having established a critical role of APP in the Ab40-mediated presynaptic enhancement, we next explored the relationship between APP-APP interactions and synapse release probability at individual hippocampal synapses. First, we tested whether APP forms homodimers at the presynaptic compartments. FRET spectroscopy enables studying conformational changes between fluorescently tagged proteins at the single-synapse level (Laviv et al., 2010) by providing an accurate measure of possible changes in the relative distance (<100 Å ) and/or orientation between fluorophores. We transfected hippocampal cultures with APP C-terminally tagged with mCitrine (APP Cit ) and with Cerulean (APP Cer ) ( Figure 2A ). FRET measurements were taken from boutons of hippocampal neurons (Figures 2B and S4A) . Presynaptic localization of the tagged APP molecules in boutons was confirmed by colocalization of APP Cit with cyan fluorescent protein (CFP)-tagged synapsin Ia protein (data not shown). We measured the steady-state mean FRET efficiency (E m ) utilizing the acceptor photobleaching method ( Figures 2C and 2D ), which dequenches the donor (Cer). FRET efficiency was measured in the presence of tetrodotoxin (TTX), which blocks spike generation, allowing only miniature synaptic release. To estimate E m using a spectroscopic approach, Cer/Cit emissions were collected in the range of 400-600 nm using a 440 nm excitation wavelength at individual presynaptic boutons expressing APP Cer and APP Cit proteins. A typical emission spectrum is displayed in Figure 2D . High-magnification confocal images ( Figure 2B ) of the presynaptic bouton (marked by arrowhead) show an increase in Cer fluorescence after Cit photobleaching ( Figure 2C ), indicating dequenching of the donor and the presence of FRET. Quantitative analysis of FRET signals between APP Cer and APP Cit proteins across 86 functional boutons from seven experiments under miniature synaptic activity revealed a mean E m of 0.14 ± 0.01 ( Figure 2E ). The FRET level varied across different boutons (coefficient of variation of 77%), suggesting different APP-APP conformational states at the single-bouton level. Notably, higher FRET levels were detected between APP Cer and APP Cit proteins expressed in APP À/À cultures, which were significantly reduced by coexpression of the nontagged APP (APP NT , Figure 2E ). These data indicate that either endogenous or exogenous nontagged APP molecules interact with the tagged APP, resulting in FRET reduction as predicted. Quantification of APP Cit expression in axons of APP À/À neurons demonstrated amounts lower than or comparable to endogenous presynaptic APP expression in WT neurons ( Figure S3 ), suggesting that FRET can occur under physiologically relevant APP levels. To rule out nonspecific association due to overexpression of the tagged proteins, we cotransfected APP Cer and a nonrelated protein subunit of GABA B Rs, GB 1a , C-terminally tagged with Cit (GB 1a Cit ). These two tagged proteins showed negligible FRET ( Figure 2E ). Furthermore, background enhancement of Cer emission, assessed by photobleaching at 515 nm in neurons expressing only APP Cer , was <2% ( Figure 2E ). Therefore, the higher FRET efficiencies measured between APP Cer and APP Cit (p < 0.0001) are due to the specific associations of APP Cer and APP Cit proteins. Altogether, these data indicate that individual APP molecules occur in close proximity in excitatory hippocampal boutons.
APP-APP Interactions Correlate to Release Probability at Excitatory Synapses
Because release probability is highly heterogeneous across hippocampal synapses (Laviv et al., 2010) , we asked whether APP-APP interactions vary across individual synapses and correlate to synapse release probability. To directly address these questions, we monitored FM destaining kinetics, a reliable (G) Reduction in neuronal and synaptic activity decreased APP Cer -APP Cit FRET efficiency: tetrodotoxin (TTX, 0.5 mM; n = 51-75, p < 0.0001); u-conotoxin (CgTx) and u-agatoxin (AgaTx) in the presence of TTX (n = 51-59, p < 0.001). E m was decreased in immature neurons (4-5 DIV, young: n = 30, N = 6, p < 0.01) and by tetanus toxin (TeTx: n = 35, p < 0.05) and was significantly higher (p < 0.01) than nonspecific APP Cer -GB1a Cit FRET. Error bars represent SEM.
(H) Increase in neuronal and synaptic activity induces an augmentation in APP Cer -APP Cit E m : gabazine (GBZ: n = 40, N = 5, p < 0.002), an increase in [Ca 2+ ] o to 4.8 mM (High Ca 2+ : n = 38, p < 0.002); high-frequency 100 Hz stimulation (n = 14, p < 0.001). The extracellular solution included AP-5 (50 mM) and DNQX (10 mM). Error bars represent SEM.
boutons demonstrate a positive correlation between E m and the rate of FM destaining (Spearman r = 0.8, p < 0.01; Figure 2F 2 ). These results suggest that APP-APP interactions correlate to release probability in excitatory hippocampal boutons.
Regulation of APP-APP Interactions by Neuronal and Synaptic Activity
We next asked whether APP-APP interactions could be regulated by the level of neuronal and synaptic activity. Activity levels were altered using pharmacological agents or electrical stimulation. FRET efficiency under spontaneous neuronal activity was 0.24 ± 0.015 (no blockers, Figure 2G ). Spike blockade by 0.5 mM TTX triggered a 33% decrease in E m (p < 0.001; Figure 2G) . To assess the changes in interactions between APP Cer and APP Cit in the same synapse before and after pharmacological treatment, we utilized the sensitized emission method by monitoring the ratio of Cit to Cer emission under Cer excitation (FRET ratio, defined as FR). FR was also lowered after TTX application (p < 0.0001; Figure S4A ). Notably, TTX had no effect on E m in APP molecules containing the endoplasmic reticulum (ER) retaining motif KKQN (Shaked et al., 2006 ) (APP-KK, p = 0.75; Figure S4B ). Noteworthy, FRET between APP-KK was reduced, but not abolished, indicating that the pool of APP in the ER exists also as a complex. These results indicate that neuronal activity may alter the number and/or conformation of APP-APP complexes at the plasma membrane.
To test whether APP-APP interactions are regulated by neurotransmitter release, we measured the effects of presynaptic calcium channels or soluble NSF attachment protein receptor (SNARE)-dependent exocytosis blockers on APP conformation. Blocking presynaptic Ca 2+ flux through N-and P/Q-type calcium channels by u-conotoxin and u-agatoxin resulted in reduction of E m by 62% (p < 0.01; Figure 2G ). Notably, measuring FRET between APP Cer and APP Cit in immature (3-4 days in vitro
[DIV]) neurons, which lack the ability to recycle vesicles, revealed a 75% reduction in E m (p < 0.01; Figure 2G ) compared with mature (12-14 DIV) cultured neurons. Finally, blocking SNAREdependent vesicle exocytosis by tetanus toxin (TeTx) reduced FRET by 65% (p < 0.05; Figure 2G ) but did not completely abolish FRET between APP Cer and APP Cit as revealed by a comparison to the negative control (between APP Cer and GB1a Cit , p < 0.01; Figure 2G ). These results indicate that synaptic activity is not necessary for the basal APP-APP precoupling but is required for the modulation of interactions between APP molecules. Next, we explored whether these APP-APP interactions can be tuned by spiking and synaptic release properties in the opposite direction as well. Boosting neuronal activity by applying the GABA(A) receptor blocker gabazine (GBZ, 30 mM) or by elevating the extracellular Ca 2+ levels from 1.2 to 4.8 mM (high Ca 2+ )
caused a 42% increase in FRET in both cases (p < 0.002; Figures  2H and S4C ). Moreover, high-frequency (100 Hz) stimulation of neurons triggered an 86% increase in FRET (p < 0.0001; Figure 2H and S4D) . Notably, high-frequency stimulation had no effect on E m in the presence of TeTx ( Figure S4E ), indicating that SNARE-dependent vesicle release is required for changes in APP-APP interactions. Altogether, these results indicate that APP-APP interactions are positively modulated by neuronal and synaptic activity.
Ab as the Mediator of Activity-Dependent APP-APP Interactions
Because extracellular Ab concentration is directly regulated by neuronal and synaptic activity (Cirrito et al., 2005; Kamenetz et al., 2003) , we asked whether Ab employs feedback regulation by mediating the APP-APP conformational changes. To this end, we utilized APP-M596V, which contains a point mutation that blocks b-secretase cleavage and therefore Ab production (Citron et al., 1995) . APP-M596V Cer and APP-M596V Cit were transfected in APP-KO cultures to ensure the lack of Ab production and release. APP-M596V resulted in 2-fold lower (p < 0.0001) basal FRET (0.12 ± 0.014; Figure 3A , no blockers) compared to APP-WT ( Figure 2G , no blockers). Moreover, APP-M596V abolished bidirectional APP-APP FRET changes by neuronal activity (p > 0.6; Figure 3A ). We then directly explored the ability of Ab to induce APP-APP conformational changes. First, we examined whether Ab40 induces FRET changes between the tagged APP molecules in a heterologous expression system using human embryonic kidney 293 cells. Ab40 induced a 28% increase in the APP-APP FRET ratio (p < 0.0001; Figures S5A and S5B). We next assessed the direct effects produced by changes in [Ab] o on FRET between APP Cer and APP Cit expressed in presynaptic boutons of hippocampal neurons. Application of 100 pM Ab40 monomers or AbS26C dimers to WT neurons increased E m by 65% ± 12% and 58% ± 16%, respectively ( Figure 3B ). Ab40 monomers triggered a 90% increase in FRET efficiency in TeTx-treated neurons ( Figure 3C ), meaning that synaptic activity is not required for the effect of Ab on APP-APP interactions. In addition, a 1.5-fold increase in [Ab] o induced by thiorphan (Th: 0.5 mM, 10 min) (Abramov et al., 2009) , an inhibitor of the Ab-degrading enzyme neprilysin, produced a 69% ± 14% increase in E m ( Figure 3B ). Reducing [Ab] o by chelating endogenously released Ab via antibodies against Ab decreased E m to 57% ± 9% (HJ5.1 antibody, p < 0.01; Figure 3B) and 58% ± 9% (82E1 antibody that does not recognize a full-length APP, p < 0.05; Figure 3B ), respectively. Moreover, blocking Ab production by preincubation with g-secretase inhibitor L-685,458 (GSI; 0.2 mM, 12 hr) reduced FRET by 51% ± 14% (p < 0.01), while addition of Ab40 to neurons pretreated with GSI increased FRET by 101% ± 15% compared to neurons treated with g-secretase inhibitor (p < 0.01; Figure 3B ). Notably, thiorphan was not effective in neurons pretreated with g-secretase inhibitor ( Figure 3B ), confirming specificity of its effect through Ab. Finally, we measured FRET between APP Cer and APP Cit efficiency in neuronal cultures produced from APP/PS1 transgenic mice (Jankowsky et al., 2004) , an animal model of familial AD. APP/PS1 neurons overproduce Ab under varying patterns of neuronal activity (Dolev et al., 2013) , and indeed they displayed higher FRET compared with WT neurons (p < 0.0001; Figure 3D ). Moreover, the application of thiorphan caused an additional 36% FRET increase in APP/PS1 boutons (p < 0.0001; Figure 3D ).
To verify these results and to determine the effect of Ab on FRET efficiency within the fraction of interacting molecules (E i ), we utilized 2pFLIM methodology (Bacskai et al., 2003; Yasuda et al., 2006) . In this method, a shortening in donor lifetime is indicative of FRET. For this purpose, we used monomeric enhanced green fluorescent protein (mEGFP) and mCherry as the donor and acceptor, respectively. mEGFP fused C terminally to APP (APP mEGFP ) has a monoexponential lifetime decay, dis- Error bars represent SEM. (B) APP Cer -APP Cit E m increased with the application of 0.5 mM thiorphan (Th: n = 60-66, p < 0.001), 100 pM Ab40 monomers (n = 54-57, p < 0.001), and 100 pM
[Ab40S26C] 2 (n = 43-54, p < 0.005) and decreased with the application of HJ5.1 antibody against Ab (10 mg/ml, n = 36-47, p < 0.01) and 82E1 antibody against Ab (5 mg/ml, n = 19-23, p < 0.05). g-secretase inhibitor (GSI) reduced APP Cer -APP Cit E m (L-685,458, 0.2 mM: n = 27, p < 0.01). Application of thiorphan had no effect on Figure 3H ). Conversely, blocking Ab production by GSI increased t AD to 2.05 ± 0.03 (p < 0.0001; Figure 3H ), resulting in a decrease in the E i to 0.17 ± 0.01 (p < 0.0001; Figure 3I ). Neither Ab40 nor GSI affected the relative fraction of APP mEGFP proteins that interact with APP mCherry (p > 0.4; Figure 3J ), indicating that the total number of APP-APP complexes per synapse does not seem to be affected by Ab. Altogether, these results suggest that Ab40 is the extracellular mediator translating alterations in neuronal activity to APP-APP conformational changes.
Ab40 Increases the Fraction of APP Homodimers at the Cytoplasmic Membrane Next, we determined the stoichiometry of APP-APP interactions and its regulation by Ab40 at the cytoplasmic membrane. Because spatial resolution of existing imaging methods is insufficient to address this question at small central synapses, we performed single-molecule subunit counting experiments (Ulbrich and Isacoff, 2007) on homomeric APP in the plasma membrane of Xenopus oocytes. Upon fusion of mEGFP to the C terminus of APP (APP mEGFP ) and low-density expression in oocytes, we observed sparse, well-resolved and stationary spots of green fluorescence on the plasma membrane using total internal reflection fluorescence (TIRF) microscopy ( Figure 4A 1 ) . The photobleaching of a single mEGFP is a discrete process; thus, the fluorescence intensity of a protein complex with one or several mEGFP molecules drops in a stepwise fashion, and the number of steps reflects the number of mEGFP-tagged subunits in the complex. Fluorescence intensity trajectories (e.g., Figure 4B 1 ) show that the majority of the APP mEGFP spots bleached in one step, with smaller numbers in two steps (Figure 4C 1 APP mEGFP dimers between the intracellular compartments and the plasma membrane. Given the immobility of bright fluorescent APP mEGFP spots, we explored the second possibility by deletion of the APP-GYENPTY internalization motif that inhibits clathrindependent APP endocytosis (Perez et al., 1999) . Notably, APP-GYENPTY deletion resulted in 1.6-fold increase in the fraction of APP-DGYENPTY mEGFP spots bleached in two steps to 17.7% ± 1.1% ( Figures 4D 1 -4F 1 and 4H ). However, Ab40 induced an additional 1.6-fold increase in the fraction of APP-DGYENPTY mEGFP spots bleached in two steps (28.6% ± 2%;
Figures 4D 2 -4F 2 and 4I), similarly to its effect in WT APP mEGFP molecules. Thus, Ab40 increases the fraction of APP homodimers at the plasma membrane irrespective of APP internalization.
The E1 APP Domain Binds Ab40 Monomers and Dimers
Previous studies suggested two potential APP regions that could directly interact with Ab: (1) the Ab homologous sequence on APP (Shaked et al., 2006) and (2) the N-terminal APP18-119 domain (Melchor and Van Nostrand, 2000; Van Nostrand et al., 2002) . Because deletion of the N-terminal growth-factor-like domain (GFLD) from APP abolished the correlation between APP-APP conformation and release probability ( Figure 2F ), we explored direct interactions between Ab40 monomers or Ab40S26C dimers and the purified E1 domain of APP (Leu28-Ala198) that includes GFLD. We expressed and purified the E1 segment, as described previously (Dahms et al., 2010) . Purified E1 protein was primarily monomeric, as determined by size-exclusion chromatography multiangle light scattering ( Figure S6A ), and exhibited a predominantly helical secondary structure ( Figure S6B ), consistent with the published crystal structure and indicative of proper folding. To test whether E1 directly interacts with the smallest Ab40 species, we performed a crosslinking assay with the purified protein and Ab40 peptide. To minimize nonspecific crosslinking, a mild crosslinker (disuccinimidyl suberate [DSS] ) was used at a low concentration (50 mM). Following reaction of E1 protein with different concentrations of monomeric Ab40 in the presence of DSS, crosslinked products were resolved by SDS-PAGE and detected by the 6E10 antibody against the Ab40 N terminus ( Figure 5A ). Complex formation was detected between E1 ($21 kDa) and monomeric Ab40, revealing a 25 kDa band (lane 1). Notably, higher concentrations of monomeric Ab40 yielded an additional 29 kDa band, corresponding to the complex of E1 with two molecules of Ab40 (lanes 2 and 3), suggesting that the binding to E1 may induce Ab40 dimerization. Increasing the E1 concentration revealed increased crosslinking between E1 and either mono- Next, we asked whether Ab40 binds to endogenous APP expressed in neurons. For this purpose, hippocampal cultures were incubated with biotinylated monomeric Ab40 (Ab40-biotin) and then fixed and visualized with alkaline phosphatase conjugated to streptavidin using nitro-blue tetrazolium chloride/ 5-bromo-4-chloro-3'-indolyl phosphate p-toluidine salt dye for substrate as shown in Figure 5B . Saturable, concentrationdependent Ab40-biotin binding to WT hippocampal neurons was detected ( Figure 5C ). Given the wide variety of proposed Ab binding candidates, we quantitated the contribution of APP to the Ab40-biotin signal detected in WT neurons. Notably, the fraction of the bound Ab40-biotin was reduced by 48% in APP À/À neurons in comparison to those in WT neurons (p < 0.0001; Figure 5D ). Moreover, preincubation of WT cultures with the 22C11 antibody raised against APP residues 66-81, the potential Ab binding epitope, reduced the bound Ab40-biotin fraction by 46% (p < 0.001; Figure 5D ), consistent with the 22c11 antibody preventing Ab40-biotin binding to APP. Notably, neither 22c11 antibody nor Ab40 affected the abundance of APP molecules at the cell surface as estimated by TIRF microscopy (p > 0.2; Figures S5E and S5F ). Taken together, these results suggest that neuronal APP represents a bona fide candidate for association with monomeric Ab40 and dimeric Ab40S26C species.
APP-GFLD Is Critical for Ab-Induced Changes in APP-APP Interactions
To explore whether the N-terminal APP domain is essential for the Ab-induced changes in APP-APP interactions, we tested the deletion of the N-terminal GFLD (Rossjohn et al., 1999) of APP (D22-128; APP-DGFLD) on FRET between APP molecules ( Figure 6A ). The basal FRET levels were not significantly different between APP-DGFLD and APP-WT proteins (p > 0.1; Figure 6B ). However, in APP-DGFLD molecules, FRET lost its sensitivity to all manipulations aimed at changing [Ab] o (p > 0.4; Figures 6C, S5C, and S5D), suggesting that the APP-GFLD is required for Ab-induced APP-APP conformational changes. It is noteworthy that the GFLD deletion abolished the observed correlation between FRET efficiency and FM dye release upon stimulation (Spearman r = 0.2, p = 0.5; Figure 2F 2 ). Moreover, addition of the 22c11 antibody raised against the APP66-81 region within the APP-GFLD increased the basal FRET (p < 0.01; Figure 6B ) and prevented further FRET modulation by TTX and Ab40 (p > 0.4; Figure 6D ). Next, we examined the importance of the Ab homologous sequence on APP, which has been suggested to directly bind Ab (Shaked et al., 2006) , by replacing it with the cognate region from APLP2, the sequence of which is divergent from APP (APP-APLP2; Figure 6A ). Both basal FRET ( Figure 6B ) and its regulation by TTX and Ab40 ( Figure 6E ) were preserved in the chimeric APP-APLP2 protein, thus ruling out the Ab homologous region in APP as essential for Ab-dependent modulation of APP-APP interactions. These experiments suggest that the GFLD of APP constitutes the molecular determinant that regulates Ab-mediated, activity-dependent modulation of conformational changes within APP homodimers.
APP-GFLD Is Required for the Ab-Mediated Presynaptic Enhancement
Because Ab mediates enhancement of basal synaptic vesicle release, we next examined whether it does so through the APP-GFLD. First, we compared the effect of Ab on synaptic vesicle recycling evoked by 0. APP-GFLD is essential for the Ab-mediated presynaptic enhancement.
APP/G o Protein Signaling Complex Mediates Presynaptic Enhancement by Ab
We asked how APP-APP conformational changes are transduced to augment synaptic release probability. Previous studies proposed that the APP forms a complex with G o protein (Nishimoto et al., 1993; Swanson et al., 2005) . Thus, we explored whether G i/o proteins mediate Ab-induced presynaptic enhancement by testing the effect of pertussis toxin (PTX), which catalyzes the ADP-ribosylation of a subunits of the heterotrimeric G i/o protein and uncouples it from the receptor, on the effect of thiorphan or Ab40 on synaptic vesicle release. We found that PTX profoundly reduced the effects of both thiorphan and Ab40 on synaptic vesicle release (p < 0.0001; Figure 7A) . (Laviv et al., 2011) . Figure 7B ). Notably, deletion of the APPHis657-Lys676 cytoplasmic domain, which has been proposed to mediate APP's interaction with G o protein (Nishimoto et al., 1993; Okamoto et al., 1995) , significantly reduced APP FRET with Ga o CFP and Gg 2 CFP (APP-D657-676; Figure 7B ). The deletion of the APP-GFLD reduced APP FRET with Gb 1 CFP and Gg 2 CFP ( Figure 7C ).
The application of Ab40 or 22c11 reduced APP Cit -Gg 2 CFP and APP Cit -Gb 1 CFP FRET ( Figure 7D ), pointing to a modulation of evoked by low-frequency stimulation were measured by highaffinity fluorescent calcium indicator Oregon Green 488 BAPTA-1 AM. Ab40 had no effect on resting Ca 2+ -dependent fluorescence, whereas it increased the size of action-potentialdependent fluorescence transients (DF/F; Figure 7E ). Ab40 induced a potentiation of presynaptic Ca 2+ transients by $22% in WT neurons (p < 0.001; Figures 7E and 7F indicating an involvement of Gbg subunits in this presynaptic modulation.
Ab Regulates Presynaptic APP-APP Interactions in Hippocampal Tissue
Finally, we extended the scope of our in vitro and cell-culture study to acute hippocampal slices to gain information on the regulation of presynaptic APP-APP interactions by extracellular Ab levels in native brain tissue. We generated two lentiviral (LV) vectors containing APP mEGFP and APP mCherry driven by the CaMKII promoter for selective expression in excitatory neurons. Concentrated viral particles of both LV vectors were injected in the dentate gyrus (DG) of the hippocampal formation using a stereotactic apparatus. After 1-2 months, the hippocampi of the injected adult mice were sliced and imaged. First, we injected APP mEGFP and APP mCherry LVs in the DG of APP À/À mice. Half of the infected granule cells coexpressed APP mEGFP and APP mCherry in the somatodendritic and axonic compartments of the DG (Figures 8A and 8B ). In the CA3 area ( Figure 8B ), fluorescence was mainly observed in the stratum lucidum where the mossy fibers project and make synapses with postsynaptic cells. Tagged APP molecules appeared mainly as punctate with a diameter of 2-5 mm that are reminiscent of the giant and small mossy terminals (Acsá dy et al., 1998) . Using 2pFLIM, we measured the lifetime of APP mEGFP at the mossy terminals coexpressing APP mCherry . The lifetime decay of the interacting proteins was 1.94 ± 0.04 ns ( Figure 8C ), 19% lower than the one measured at terminals expressing APP mEGFP alone (2.4 ± 0.02 ns). These data indicate an interaction between APP mEGFP and APP mCherry molecules at mossy terminals, corresponding to 0.24 ± 0.02 FRET efficiency ( Figure 8D ). Application of monomeric Ab40 (20 nM, 30 min) led to a decrease in the lifetime decay of APP mEGFP to 1.74 ± 0.07 ns in the terminals coexpressing APP mCherry (p < 0.0001; Figure 8C ), resulting in a 42% increase in FRET efficiency to 0.34 ± 0.03 (p < 0.0001; Figure 8D ). Similar to the data in cultured neurons, the fraction of interacting molecules per synapse was not changed by Ab40 application (p = 0.3; Figure 8E ).
Next, we injected APP mEGFP and APP mCherry LVs in the DG of WT mice. To increase the extracellular levels of endogenous Ab, we inhibited its neprilysin-mediated degradation by thiorphan. Application of thiorphan (20 mM, 30 min) lead to a decrease in the lifetime decay of APP mEGFP from 1.89 ± 0.03 ns to 1.71 ± 0.04 ns in the terminals coexpressing APP mCherry (p < 0.0001; Figure 8C ), resulting in a 34% increase in FRET efficiency to 0.39 ± 0.02 (p < 0.0001; Figure 8D ) while not affecting the fraction of interacting molecules per synapse (p > 0.4; Figure 8E ). These results indicate that extracellular Ab promotes presynaptic APP-APP interactions in hippocampal tissue.
DISCUSSION
Elucidating the mechanisms by which Ab peptides regulate synaptic transmission is essential for understanding normal synaptic function as well as early synaptic dysfunctions in AD.
In the current study, we found that APP binds Ab40 monomers and dimers, increases the fraction of APP homodimers at the plasma membrane, and induces activity-dependent APP-APP conformational changes. APP homodimer activation, in turn, leads to structural rearrangements within the presynaptic APP/ G o protein signaling complex, resulting in enhancement of presynaptic calcium flux and, thus, synaptic vesicle exocytosis. We identified the APP growth-factor-like domain as a critical determinant of Ab40-induced changes in APP-APP interactions and release probability. Collectively, our data delineate APP homodimer as a presynaptic receptor that translates local changes in the extracellular Ab levels to modulation of synaptic release probability. This mechanism may maintain basal neurotransmitter release under physiological conditions and initiate hippocampal hyperactivity under pathological conditions, promoting a positive feedback loop leading to extracellular Ab accumulation.
Activity Promotes APP-APP Interactions at Hippocampal Boutons
Previous studies suggest that APP can form homodimers and higher-order oligomers in heterologous expression systems (Eggert et al., 2009; Kaden et al., 2009; Munter et al., 2007; Scheuermann et al., 2001 ) and in brain homogenates (Bai et al., 2008) . Moreover, APP homodimerization seems to affect Ab generation: dimerization strength in the transmembrane GxxxG APP domain within the Ab sequence regulates the g-secretase cleavage of APP, increasing the Ab42/40 ratio (Munter et al., 2007) . However, induced dimerization at the APP C terminus reduced the total Ab production (Eggert et al., 2009 Figure 2E ). While FRET methodology allows deciphering intermolecular interactions in small subcellular structures such as synapses (Laviv et al., 2010) , it requires expression of fluorescent-tagged proteins, raising the question of the possible effects of protein overexpression. However, the following facts suggest that homophilic APP interactions occur at physiologically relevant APP levels. First, the level of the tagged APP expression in the axons of APP À/À neurons was similar to the endogenous APP level in WT neurons ( Figure S3 ). Second, the functional effect of Ab40 in APP À/À neurons expressing the tagged APP-WT was comparable to those induced by Ab40 in WT neurons. The observed intermolecular APP-APP FRET displayed considerable variability among boutons ( Figure 2F 2 ). This heterogeneity may derive from differences in the APP length (processed and full), local mechanisms regulating APP-APP interactions or intersynapse differences in the microenvironment. Indeed, APP-APP interactions display robust, rapid, and bidirectional regulation by synaptic activity. Basal APP homodimerization did not require synaptic activity, in agreement with an earlier study suggesting that APP dimers can form in the ER shortly after its synthesis (Scheuermann et al., 2001) . In contrast, APP-APP interactions were modulated by spiking rate, Ca 2+ flux through presynaptic voltage-gated calcium channels, and synaptic release probability (Figure 2 ), while neuronal activity did not affect FRET between APP-KK proteins containing an ER retention signal. We conclude that the fraction of APP homodimers localized at the cytoplasmic membrane is regulated by activity-dependent conformational modifications.
Ab as the Mediator of Activity-Dependent APP-APP Interactions Spiking rate and synaptic activity could affect APP-APP conformation either (1) by directly changing the membrane potential or (2) through activity-dependent release of a putative mediator. This second possibility, where extracellular Ab40 serves as the mediator inducing APP-APP structural changes, is supported by the following evidence: (1) Ab40 monomers and Ab40S26C dimers directly bind to the E1 domain of the APP; (2) Ab40 increases the fraction of APP dimers at the plasma membrane and FRET between APP molecules in heterologous expression systems; (3) activity-dependent FRET changes were abolished in neurons lacking Ab production following introduction of the APP-M596V mutation preventing b-secretase cleavage; and (4) FRET was altered by direct regulation of extracellular Ab levels. Specifically, both antibody against Ab that does not recognize full-length APP and g-secretase inhibitor reduced FRET. On the other hand, inhibition of Ab degradation by thiorphan, the addition of Ab40 monomers or Ab40S26C dimers, and an increase in Ab production by APP/PS1 mutations boosted FRET between APP molecules. Notably, the GFLD of APP constitutes the molecular determinant required the activity-induced and Ab-mediated APP-APP conformational changes. What are the Ab species that induce an increase in glutamate release? Our data provide evidence that Ab40 monomers and dimers, the smallest Ab species, regulate presynaptic function through activation of APP homodimers in hippocampal boutons. This finding highlights a previously neglected role of Ab40 monomers in synaptic dysfunctions and is in contrast to an earlier study in which cell media containing Ab monomers and SDSstable low-n oligomers had no effect on presynaptic function estimated by paired-pulse ratio (Townsend et al., 2006) . However, Ab dimers (from human brain as well as synthetic crosslinked dimers) were suggested to represent the principal and the smallest species that cause postsynaptic depression of glutamatergic transmission via loss of dendritic spines, blockade of long-term potentiation, and increase in long-term synaptic depression (Shankar et al., 2008) . Notably, later biophysical characterization of Ab40S26C dimers point to the fact that it is not dimers per se but rather protofibrils that mediate this activity (O'Nuallain et al., 2010) . Thus, it seems that the smallest Ab species, monomers and dimers, enhance presynaptic function, while higher-molecular-weight prefibrillar assemblies may initiate postsynaptic depression in excitatory synaptic connections.
APP Homodimer as a Presynaptic Ab40
Receptor Does the APP homodimer, similar to the receptor tyrosine kinases, trigger signal transduction through ligand-promoted receptor dimerization? Although the APP structure is reminiscent of other cell-surface receptors involved in signal transduction (Kang et al., 1987) , the role of APP as a bona fide surface receptor has remained speculative. Physical interaction between pathological Ab levels/conformations and APP was proposed a decade ago as a mechanism inducing neuronal death in AD (Lorenzo et al., 2000; Shaked et al., 2006; Van Nostrand et al., 2002) . However, in addition to APP, a wide range of other putative Ab receptors can induce neurotoxicity, suggesting biophysical and structural heterogeneity of toxic Ab species or, alternatively, nonspecific interactions between a mixture of toxic peptides with cellular membranes and proteins (Benilova et al., 2012) .
Our data highlight the role of APP as a bone fide surface Ab40 receptor that triggers a signaling cascade leading to augmentation of synaptic vesicle release in hippocampal neurons. The fulllength APP may undergo cleavage by either a-or b-secretase, resulting in the shedding of large extracellular portions of APP termed APPsa or APPsb, respectively. Notably, b-secretase mainly cleaves APP in the endosomal pathway (Koo and Squazzo, 1994) , while ADAM10 a-secretase resides in the postsynaptic densities (Marcello et al., 2007) . Thus, the presynaptic plasma membrane appears to be the primary location of unprocessed APP molecules that transduce changes in Ab levels to synaptic strength.
How does Ab exert its presynaptic effect? Following secretion, Ab forms the Ab:APP complex that triggers APP-APP conformational changes, leading to an increases in the presynaptic Ca 2+ flux and subsequent potentiation of synaptic vesicle release. Because Ab-mediated enhancement of Ca 2+ flux or vesicle release was prevented by either PTX or Gbg scavenger, we concluded that G i/o proteins are involved in this signaling cascade. Moreover, we observed a close interaction between APP molecules and Ga o b 1 g 2 protein subunits at individual presynaptic boutons, suggesting a formation of the signaling complex that is undergoing conformational changes by the smallest Ab40 species. Reduction in APP/G o protein interactions at various stages of cognitive decline in AD patients (Shaked et al., 2009) indicates the importance of the APP/G o protein signaling complex in AD progression.
Synapse Hyperactivity and Alzheimer's Disease Numerous human and animal studies suggest the role of cortical and hippocampal hyperactivity in AD pathogenesis. High default activity in specific brain regions of young adults correlates with the spatial pattern of amyloid depositions in elderly individuals with AD (Buckner et al., 2005) . Aberrant neuronal activity in the hippocampus and cortex has been reported in humans with mild cognitive impairment (Bakker et al., 2012) , in AD patients (Vossel et al., 2013) , and in familial AD transgenic animal models (Busche et al., 2008; Palop et al., 2007; Verret et al., 2012) . Various molecular and cellular mechanisms may contribute to brain hyperactivity in AD. For example, deficits in parvalbumin-positive interneurons have been proposed to underlie abnormalities in network synchrony and cognitive functions in APP transgenic mice (Verret et al., 2012) . Young APP/PS1 transgenic mice exhibit increased basal glutamate release in CA3-CA1 hippocampal connections (Dolev et al., 2013) and increased spontaneous Ca 2+ transients in vivo in pyramidal neurons in the CA1 region of hippocampus (Busche et al., 2012) . Notably, hyperactivity of pyramidal neurons has been reported to occur before neuronal depression and plaque deposition in the hippocampus of APP/PS1 mice (Busche et al., 2012) . Based on the current work, we propose that increases in the extracellular level of Ab monomers and dimers in the early stages of AD development may augment signaling via APP homodimers, leading to hyperactivity of excitatory hippocampal synapses ( Figure S8 ). Potentiation of synaptic vesicle release in turn causes a subsequent increase in Ab40 production and release (Cirrito et al., 2005; Dolev et al., 2013) , leading to a positive feedback loop between the extracellular Ab concentration and basal glutamate release. Under physiological conditions, an increase in Ab-mediated APP homodimerization may induce a feedback inhibition of Ab production (Eggert et al., 2009) to maintain steady-state Ab levels and basal glutamate release. Disruption of this negative feedback loop by genetic-or experience-dependent factors may cause a gradual increase in the extracellular levels of Ab monomers and dimers during the early AD stages, leading to excessive activation of APP homodimers at the plasma membrane and subsequent hyperactivity of excitatory hippocampal synapses. The described presynaptic hyperactivity may initiate neural dysfunctions by two possible ways. First, it may cause deficits in short-term synaptic plasticity (Abramov et al., 2009) . Second, it may facilitate the kinetics of Ab oligomerization and thus depress synapses and induce synapse loss. Such an Ab-induced synaptic reorganization may promote homeostasis of synaptic output across the dendrites but reduce the ability of synaptic networks to undergo experience-dependent modifications. It remains to be seen whether excessive activation of APP homodimers by Ab emerges as the first molecular step contributing to hippocampal hyperactivity in the most frequent, sporadic AD.
EXPERIMENTAL PROCEDURES Primary Hippocampal Cultures and Acute Hippocampal Slices
Primary cultures of CA3-CA1 hippocampal neurons were prepared from newborn Sprague-Dawley rats and from APP À/À (Zheng et al., 1995) and corresponding WT mice (C57BL/6J background) on postnatal days 0-2, as described previously (Abramov et al., 2009) . Acute hippocampal slices were prepared from 2-to 3-month-old APP À/À and BALB/c mice 1 month after lentivirus injections. All animals were kept in a normal light/dark cycle (12 hr/12 hr) with three animals per cage. Coronal slices (400 mm) of hippocampus were prepared as described before (Abramov et al., 2009) . Slices were transferred to a submerged recovery chamber at room temperature containing oxygenated (95% O 2 and 5% CO 2 ) artificial cerebrospinal fluid (ACSF) for 1 hr before the experiment. The ACSF contained, in mM, NaCl, 125; KCl, 2.5; CaCl 2 , 1.2; MgCl 2 , 1.2; NaHCO 3 , 25; NaH 2 PO 4 , 1.25; glucose, 25. All animal experiments were approved by the Tel Aviv University committee on animal care.
Confocal Imaging
Hippocampal neurons were imaged using a FV1000 spectral Olympus confocal microscope using a 60 3 1.2 numerical aperture (NA) water-immersion objective. The experiments were conducted at room temperature in extracellular Tyrode solution containing (in mM) NaCl, 145; KCl, 3; glucose, 15; HEPES, 10; MgCl 2 , 1.2; CaCl 2 , 1.2 (pH adjusted to 7.4 with NaOH). To isolate miniature synaptic activity, TTX (0.5 mM) was added to the extracellular solution when indicated.
FRET Imaging and Analysis
Intensity-based FRET imaging was carried as described before (Laviv et al., 2010) . Donor dequenching due to the desensitized acceptor was measured from Cer emission (460-500 nm) before and after the acceptor photobleaching. Mean FRET efficiency, E m , was then calculated using the equation E m = 1 À I DA /I D , where I DA is the peak of donor emission in the presence of the acceptor and I D is the peak after acceptor photobleaching (see Supplemental Experimental Procedures for details).
2pFLIM Imaging and Analysis
For imaging in primary cultures, hippocampal neurons were transfected with mEGFP-tagged APP (APP mEGFP ) only or APP mEGFP together with APP tagged with mCherry (APP mCherry ) and visualized 24-36 hr later in Tyrode solution. Fluorescence lifetime images were acquired with a two-photon microscope (LSM 7 MP, Zeiss) coupled to the Becker and Hickl (BH) simpleTau-152 system. Chameleon Ti:Sapphire laser system with a 80 MHz repetition rate was used to excite the sample. Images were acquired through a Zeiss 63 3 1 NA water-immersion objective for primary cultures and through a Zeiss 20 3 1 NA water-immersion objective for the acute brain slices. A Zeiss dichroic mirror (T690) was used to separate the excitation and the emission light. An additional barrier filter was used to block emission light above 690 nm. Images of 512 3 512 pixels were acquired at a scanning speed of 1.27 ms per pixel. Emission light was separated by a dichroic mirror (555 nm), and the two fluorescent lights were filtered by two band-pass filters (500-550 nm for mEGFP and 590-650 nm for mCherry) placed in front of two hybrid GaAsP detectors (HPM-100-40, BH). The excitation wavelength was 920 nm for the donor fluorophore mEGFP and 1,020 nm for the acceptor fluorophore mCherry. The image acquisition time was 100-120 s to collect a sufficient number of photons. Images were analyzed using the SPCImage software (BH). Regions of interest were marked at boutons. The instrument response function was determined manually and was convoluted with the exponential decay. The lifetime of the donor fluorophore (mEGFP) was then fitted using a monoexponential decay model when APP mEGFP was expressed alone and biexponential one when APP mEGFP was coexpressed with APP mCherry . Monoexponential fit (F(t) = F 0. exp (Àt/tD) ) determines the time constant for APP mEGFP lifetime at boutons, t D . F 0 is the initial photon counts.
Biexponential decay model is composed of a FRET (fast) and a non-FRET (slow) components: F(t) = F 0 .[a 1 .exp (Àt/tAD) + (100 À a 1 )exp (Àt/tD) . In the case of a biexponential fit, t m was calculated as t m = a 1 .t AD + (100 À a 1 ).t D .
FM-Based Imaging and Analysis
Activity-dependent FM1-43 and FM4-64 styryl dyes have been used to estimate basal synaptic vesicle recycling and exocytosis. Action potentials have been elicited by passing 50 mA constant current for 1 ms through two platinum wires, separated by $7 mm and close to the surface of the coverslip. The extracellular medium contained nonselective antagonist of ionotropic glutamate receptors (kynurenic acid, 0.5 mM) to block recurrent neuronal activity. Synaptic vesicles were loaded with 15 mM FM4-64 or 10 mM FM1-43. FM loading and unloading were done using protocols described previously (Abramov et al., 2009) . The fluorescence of individual synapses was determined from the difference between images obtained after staining and after destining (DF). To estimate vesicle recycling/release during low-frequency stimulation, we quantified (1) the DF signal for staining by 30 action potentials at a rate of 0.2 Hz stimulation ( Figure S1A ) and (2) the FM destaining rate during 1 Hz stimulation following staining of boutons by maximal stimulation ( Figure S1C) . Detection of signals has been done using custom-written scripts in MATLAB (Mathworks) as described before (Abramov et al., 2009) .
Statistical Analysis
Error bars shown in the figures represent SEM. The number of boutons is defined by n and the number of experiments (cultures) by N. All the experiments were repeated at least in three different batches of cultures. One-way ANOVA analysis with post hoc Dunnett or Bonferroni correction was used to compare several conditions. Student's unpaired t test was used in the experiments where two populations of synapses were compared. Student's paired t test was used when the same population of synapses was tested before and after treatment. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant. 
AUTHOR CONTRIBUTIONS
H.F. designed, performed, and analyzed the experiments presented in Figures  1, 2, 3A-3D , 5B, 6, 7, and 8 and Figures S1, S3-S5, and S7 with the help of N.G. and E.S. S.F. established the 2pFLIM system and designed, performed, and analyzed the 2pFLIM-FRET experiments ( Figures 3E-3J and 8 
